A detailed history of Occidental Asset Management, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Occidental Asset Management, LLC holds 6,951 shares of EXEL stock, worth $289,509. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,951
Previous 10,657 34.78%
Holding current value
$289,509
Previous $440,000 34.32%
% of portfolio
0.04%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 07, 2026

SELL
$34.54 - $43.59 $128,005 - $161,544
-3,706 Reduced 34.78%
6,951 $289,000
Q3 2025

Oct 28, 2025

BUY
$36.22 - $46.25 $76,931 - $98,235
2,124 Added 24.89%
10,657 $440,000
Q2 2025

Jul 14, 2025

BUY
$34.13 - $46.26 $291,231 - $394,736
8,533 New
8,533 $376,000

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $13.4B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Occidental Asset Management, LLC Portfolio

Follow Occidental Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Occidental Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Occidental Asset Management, LLC with notifications on news.